0
0
April 30, 2025 – As cholera cases surge globally, new research from the University of Utah Health is challenging long-standing public health guidelines on how best to control outbreaks of the deadly disease. The findings, published in the Bulletin of Mathematical Biology, suggest that expanding the use of antibiotics beyond the most severe cases could potentially slow or even halt the spread of cholera in certain settings.
Rethinking Cholera Treatment
Traditionally, antibiotics are reserved for only the most severely ill cholera patients. This cautious approach aims to minimize the risk of the bacteria developing resistance to life-saving drugs. However, the new study, led by Dr. Lindsay Keegan and Dr. Sharia Ahmed, uses mathematical modeling to show that more widespread antibiotic use could actually have population-wide benefits.
The key insight: While antibiotics do not necessarily help most patients recover faster, they drastically reduce the period during which an infected person can spread the disease-from up to two weeks to just a couple of days. “If you take an antibiotic, you still feel better in about a day, and you stop releasing cholera into your environment,” Dr. Ahmed explained.
When More Antibiotics Make Sense
The researchers found that in areas where cholera spreads relatively slowly-such as regions with lower population density or better sanitation-treating moderate cases with antibiotics could limit the overall number of infections. This, in turn, could lead to fewer antibiotics being used overall and reduce the risk of antibiotic resistance developing.
However, in high-risk areas with rapid disease transmission, such as crowded urban centers or places lacking clean water, the benefits of expanded antibiotic use may not outweigh the risks.
Growing Urgency Amid Rising Cases
The study comes at a critical time: Cholera cases and deaths have jumped by about a third in the past year, fueled by mass displacement and natural disasters. Experts warn that as climate change intensifies and infrastructure is disrupted, outbreaks could become more frequent-even in countries previously unaffected by cholera.
“This might be an underused opportunity for cholera control,” said Dr. Keegan, emphasizing the need for more research before any policy changes are made. The team is now working to refine their models and test whether their findings hold up in more complex, real-world scenarios.
A Step Toward Better Outbreak Management
While the results are promising, the researchers caution that their work is only a first step. “The takeaway is not, ‘OK, let’s start giving people antibiotics,'” Dr. Keegan noted. “This is a first step at understanding antibiotic use as a possibility for outbreak control.”
If further studies support these findings, they could eventually inform new guidelines for managing cholera outbreaks-potentially saving thousands of lives each year.
Disclaimer:
This article is based on preliminary research findings published in the Bulletin of Mathematical Biology and reported by Medical Xpress on April 29, 2025. The study’s conclusions are drawn from mathematical modeling and require further validation in real-world settings. The information provided should not be interpreted as medical advice or as a recommendation to change current treatment protocols. For medical guidance, always consult qualified healthcare professionals.
Citations:
